Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.64 |
| ▸ | CNR2 | P34972 | 6/20 | 0.63 |
| ▸ | CNR1 | P21554 | 1/20 | 0.63 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | AGER | Q15109 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15898561 | 0.91 | CNR2 (0.67) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL13763304 | 0.91 | CNR2 (0.55) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL17888190 | 0.89 | CNR2 (0.54) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL1931740 | 0.89 | CNR2 (0.56) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL10017634 | 0.86 | CNR2 (0.54) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL6776106 | 0.86 | GLA (0.56) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL1932605 | 0.86 | CNR2 (0.54) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL7054917 | 0.85 | CNR2 (0.53) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL2462475 | 0.85 | CNR2 (0.53) | C5AR1CNR2CNR1GLASMN1; SMN2 | |
| SCHEMBL14798321 | 0.85 | GLA (0.55) | C5AR1CNR2CNR1GLASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117293321-B | Silicon anode material, preparation method thereof, anode and battery | 江苏中兴派能电池有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117293321-A | Silicon anode material, preparation method thereof, anode and battery | 江苏中兴派能电池有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116410586-A | Precipitation-resistant high-toughness polyamide composition and preparation method thereof | 万华化学（宁波）有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-113140796-A | Lithium ion battery electrolyte and lithium ion battery containing same | 东莞市杉杉电池材料有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-102145304-B | Preparation of loaded Grubbs catalyst and application of loaded Grubbs catalyst | UNIV EAST CHINA NORMAL | 2012-08-08 | — | — | CN | claimed |
| CN-102145304-A | Preparation of loaded Grubbs catalyst and application of loaded Grubbs catalyst | UNIV EAST CHINA NORMAL | 2011-08-10 | — | — | CN | claimed |
| CN-115947761-B | Ruthenium carbene catalyst, composition containing ruthenium carbene catalyst, preparation method and application of ruthenium carbene catalyst | 上海中化科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260049045-A1 | Amplificative Ethylene Detection by Activation of Latent Olefin Metathesis Catalysts and Systems | UNIVERSITY OF DENVER (US) | 2026-02-19 | — | — | US | disclosed |
| CN-119930696-A | Imidazole coordinated ruthenium carbene olefin metathesis catalyst, preparation and application thereof | 中国石油天然气股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-12139504-B2 | Vanadium alkylidene complex, synthesis and use thereof | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-11-12 | — | — | US | disclosed |
| US-20240228519-A1 | VANADIUM ALKYLIDENE COMPLEX, SYNTHESIS AND USE THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240228519-A1 | VANADIUM ALKYLIDENE COMPLEX, SYNTHESIS AND USE THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240228519-A1 | VANADIUM ALKYLIDENE COMPLEX, SYNTHESIS AND USE THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-07-11 | — | — | US | disclosed |
| US-6590048-B1 | Catalysts comprising group VIII compounds used for cyclization of crown ethers, antibiotics, veterinary medicines or perfumes | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2003-07-08 | — | — | US | disclosed |
| WO-2003011875-A1 | NOVEL TRANSITION-METAL COMPLEXES AND USE THEREOF IN TRANSITION-METAL CATALYSED REACTIONS | BAYER CHEMICALS AG (DE) | 2003-02-13 | — | — | WO | disclosed |
| EP-1037897-B1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-06-12 | — | — | EP | disclosed |
| WO-2001072421-A1 | POLYMER SUPPORTED CATALYSTS FOR OLEFIN METATHESIS | GLAXO GROUP LIMITED (GB) | 2001-10-04 | — | — | WO | disclosed |
| EP-1037897-A1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | Studiengesellschaft Kohle mbH (DE) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999028330-A1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1999-06-10 | — | — | WO | disclosed |
| EP-0921129-A1 | Highly active cationic ruthenium and osmium complexes for olefin metathesis reactions | Studiengesellschaft Kohle mbH (DE) | 1999-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12139504-B2 | Vanadium alkylidene complex, synthesis and use thereof | VDAC3, CDV3, CBR3 | C5AR1 1978/4885CNR2 1500/4885CNR1 1891/4885 |
| US-20240228519-A1 | VANADIUM ALKYLIDENE COMPLEX, SYNTHESIS AND USE THEREOF | VDAC3, CDV3, CBR3 | C5AR1 1978/4885CNR2 1500/4885CNR1 1891/4885 |
| US-20260049045-A1 | Amplificative Ethylene Detection by Activation of Latent Olefin Metathesis Catalysts and Systems | ESR1, MYC, MAX | C5AR1 4612/4885CNR2 422/4885CNR1 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.